ND-003 Tablets

· Shenzhen NewDEL Biotech, Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ND-003 Tablets, covering 2024-05-30 to 2024-05-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Pharmacokinetic of ND-003 Tablets in Healthy Adults [Phase 1]